Design and evaluation of a treatment programme for Spanish adolescents with overweight and obesity: the EVASYON Study
MetadatosMostrar el registro completo del ítem
AutorMartínez-Gómez, David; Gómez-Martínez, Sonia; Puertollano, María de los Ángeles; Nova, Esther; Wärnberg, Julia; Veiga, Óscar; Martí, Amelia; Campoy Folgoso, Cristina; Garagorri, Jesús M.; Azcona, Cristina; Vaquero, María Pilar; Redondo-Figuero, Carlos; Delgado Fernández, Manuel; Martínez, J. Alfredo; García-Fuentes, Miguel; Moreno, Luis A.; Marcos, Ascensión; EVASYON Study Group
Martínez-Gómez, D.; et al. Design and evaluation of a treatment programme for Spanish adolescents with overweight and obesity: the EVASYON Study. BMC Public Health, 9:414 (2009). [http://hdl.handle.net/10481/32999]
PatrocinadorThe authors would like to thank the Spanish Ministry of Health and Consumption (Carlos III Institute of Health. FIS. Grant PI 051579). D. Martínez-Gómez receives a predoctoral fellowship from the Spanish Ministry of Education and Science (AP2006-02464). M.A. Puertollano owned a research contract ("Juan de la Cierva") from the Spanish Ministry of Education and Science. The EVASYON study has received the award from AESAN (Spanish Agency for Food Security and Nutrition) from the Spanish Ministry of Health and Consumption to the best applied research project in 2009.
Background The prevalence of overweight and obesity (OW/OB) among adolescents worldwide has increased since the 60 s. Spain has reached one of the highest OW/OB prevalence rates among adolescents from European countries. The aim of this methodological paper is to describe the design and evaluation in the EVASYON study (Development, implementation and evaluation of the efficacy of a therapeutic programme for adolescents with OW/OB: integral education on nutrition and physical activity). Methods/Design The EVASYON was planned by a multidisciplinary team to treat OW/OB in Spanish adolescents. The EVASYON is a multi-centre study conducted in 5 hospitals in 5 Spanish cities (Granada, Madrid, Pamplona, Santander and Zaragoza) and two hundred and four OW/OB Spanish adolescents were recruited for this intervention. The treatment was implemented for approximately one-year follow-up. The adolescents were treated in groups of a maximum of 10 subjects; each group had 20 visits during the treatment period in two phases: intensive during the first 2 months (1st to 9th visits), and extensive during the last 11 months (10th to 20th visits). In order to assess the efficacy of the treatment, 8 dimensions were measured: diet; physical activity and fitness; eating behaviour; body composition; haematological profile; metabolic profile; minerals and vitamins; immuno-inflammatory markers. Moreover, genetic polymorphisms were also determined. Discussion The treatment programme developed in the EVASYON study was designed as a national pilot study to be implemented as an effective treatment for adolescents with OW/OB into the Spanish Health Care Service.